Competing Pharmaceutical Firms Slash Price on Cholesterol Drug to Improve Sales

Drug companies Sanofi SA and Regeneron Pharmaceuticals Inc announced, early this week, that they each plan to drastically cut the US list price for their highly effective—and highly-priced—cholesterol drug Praluent.  Apparently, the drugmakers are dropping the price by as much as 60 percent for some patients, after rival Amgen Inc did

Does Gum Disease Have A Key Role In Alzheimer’s?

According to an article published in Science Daily, scientists believe there is a correlation between the bacteria of chronic gum disease, Porphyromonas gingivalis (Pg)and Alzheimer’s Disease (AD). Also in an article published in the journal of Science Advances the University of Louisville researcher Jan Potempa, Ph.D., Department of Oral Immunology and